Want to see KR:000230 full AI Analyst Report?
Ildong Holdings Co., Ltd (000230) AI Stock Analysis
Ildong Holdings Co., Ltd
(Korea Exchange:000230)
The score is primarily restrained by moderate financial quality and weak technical momentum, despite very attractive valuation. Recovery is evident, but leverage, thin profitability, and historical volatility remain significant risks.
Ildong Holdings Co., Ltd (000230) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- KRW 65.32B
- Dividend Yield
- 1.77%
- Average Volume (3M)
- 24.69K
- Price to Earnings (P/E)
- 2.1
- Beta (1Y)
- 0.04
- Revenue Growth
- -3.85%
- EPS Growth
- -63.01%
- Country
- KR
- Employees
- 80
- Sector
- General
- Sector Strength
- 55
- Industry
- Drug Manufacturers - Specialty & Generic
Ildong Holdings Co., Ltd Business Overview & Revenue Model
Company Description
Ildong Holdings Co., Ltd., established in Seoul, South Korea, in 1941, operates internationally, specializing in the innovation, production, and supply of pharmaceutical goods. The company actively researches and develops novel therapeutics for chall...
Ildong Holdings Co., Ltd Financial Statement Overview
Summary
Financial recovery is supported by strong revenue growth, renewed profitability, lower leverage, and positive cash flow. However, thin margins, historical earnings and cash-flow volatility, and debt exceeding equity limit the score.
Income Statement
65PositiveBalance Sheet
52NeutralCash Flow
61Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 607.20B | 590.89B | 657.57B | 638.45B | 675.54B | 592.37B |
| Gross Profit | 229.51B | 215.14B | 232.79B | 198.89B | 239.13B | 220.83B |
| EBITDA | 53.20B | 41.49B | 124.42B | -64.04B | -116.29B | -41.66B |
| Net Income | 21.66B | 10.93B | 63.04B | -59.59B | -102.35B | -70.89B |
Balance Sheet | ||||||
| Total Assets | 790.85B | 802.86B | 854.70B | 877.00B | 862.55B | 920.76B |
| Cash, Cash Equivalents and Short-Term Investments | 80.45B | 77.81B | 94.57B | 102.48B | 136.41B | 200.84B |
| Total Debt | 196.55B | 217.02B | 324.83B | 325.36B | 299.09B | 324.09B |
| Total Liabilities | 434.34B | 457.28B | 600.70B | 707.10B | 693.45B | 737.42B |
| Stockholders Equity | 173.87B | 168.76B | 133.89B | 38.96B | 11.81B | 53.33B |
Cash Flow | ||||||
| Free Cash Flow | 26.30B | 12.83B | 1.72B | -77.26B | -95.73B | -53.28B |
| Operating Cash Flow | 37.64B | 26.86B | 17.31B | -57.77B | -74.59B | -30.54B |
| Investing Cash Flow | 19.67B | 31.26B | 22.45B | -16.34B | -32.50B | -48.87B |
| Financing Cash Flow | -61.25B | -60.71B | -32.00B | 46.34B | 31.65B | 128.09B |
Ildong Holdings Co., Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:000230, the sentiment is Negative. The current price of 5690.00 is below the 20-day moving average (MA) of 5978.50, below the 50-day MA of 6123.60, and below the 200-day MA of 8348.76, indicating a bearish trend. The MACD of -112.79 indicates Positive momentum. The RSI at 34.76 is Neutral, neither overbought nor oversold. The STOCH value of 24.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:000230.
Ildong Holdings Co., Ltd Peers Comparison
Overall Rating
KR:09676072Outperform
KR:00064061Neutral
KR:24942060Neutral
KR:00163059Neutral- KR:00023059Neutral
KR:00262051Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| KR:096760 | 72Outperform | KRW 274.34B | 3.25 | ― | 5.42% | 10.18% | 149.93% |
| KR:000640 | 61Neutral | KRW 576.52B | 6.95 | ― | 1.96% | 10.06% | -3.74% |
| KR:249420 | 60Neutral | KRW 397.78B | 8.87 | ― | 1.59% | -0.65% | ― |
| KR:001630 | 59Neutral | KRW 169.48B | 2.61 | ― | 3.93% | 1.43% | 106.56% |
| KR:000230 | 59Neutral | KRW 63.91B | 2.13 | ― | 1.77% | -3.85% | -63.01% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| KR:002620 | 51Neutral | KRW 103.16B | 12.22 | ― | 1.04% | -15.55% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| KR:000230 | Ildong Holdings Co., Ltd | 5660.00 | -3304.30 | -36.86% | |
| KR:000640 | Dong-A Socio Holdings Co., Ltd. | 86900.00 | -16225.73 | -15.73% | |
| KR:001630 | Chong Kun Dang Holdings Co., Ltd. | 35600.00 | -7796.04 | -17.96% | |
| KR:002620 | JEIL PHARMA HOLDINGS INC. | 6720.00 | -1121.77 | -14.31% | |
| KR:096760 | JW Holdings Corporation | 3965.00 | 856.99 | 27.57% | |
| KR:249420 | Ildong Pharmaceutical Co., Ltd. | 12580.00 | -14837.52 | -54.12% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026